BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32067818)

  • 21. Impact of rotavirus vaccination in Australian children below 5 years of age: a database study.
    Pendleton A; Galic M; Clarke C; Ng SP; Ledesma E; Ramakrishnan G; Liu Y
    Hum Vaccin Immunother; 2013 Aug; 9(8):1617-25. PubMed ID: 23733041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained High Effectiveness of RotaTeq on Hospitalizations Attributable to Rotavirus-Associated Gastroenteritis During 4 Years in Finland.
    Hemming-Harlo M; Vesikari T; Uhari M; Renko M; Salminen M; Torcel-Pagnon L; Hartwig S; Simondon F; Bricout H
    J Pediatric Infect Dis Soc; 2017 Nov; 6(4):317-323. PubMed ID: 27760800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Socioeconomic Impact of the Rotavirus Vaccine in Korea: Comparing the Epidemiologic and Economic Characteristics of Rotavirus Gastroenteritis Before and After the Introduction of Vaccines.
    Cho H; Lee H; Kim DS; Kim HM; Kim JH; Kim AY; Kang HY
    Pediatr Infect Dis J; 2020 May; 39(5):460-465. PubMed ID: 31990891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The changes of the epidemiology and clinical characteristics of rotavirus gastroenteritis-associated convulsion after the introduction of rotavirus vaccine.
    Kawase M; Hoshina T; Yoneda T; Kojiro M; Takahashi Y; Kusuhara K
    J Infect Chemother; 2020 Mar; 26(3):206-210. PubMed ID: 31563335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decrease of Rotavirus Gastroenteritis to a Low Level Without Resurgence for Five Years After Universal RotaTeq Vaccination in Finland.
    Hemming-Harlo M; Markkula J; Huhti L; Salminen M; Vesikari T
    Pediatr Infect Dis J; 2016 Dec; 35(12):1304-1308. PubMed ID: 27455440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil.
    Justino MC; Linhares AC; Lanzieri TM; Miranda Y; Mascarenhas JD; Abreu E; Guerra SF; Oliveira AS; da Silva VB; Sanchez N; Meyer N; Shafi F; Ortega-Barria E; Soriano-Gabarró M; Colindres RE
    Pediatr Infect Dis J; 2011 May; 30(5):396-401. PubMed ID: 21150692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of rotavirus vaccine in preventing severe gastroenteritis in young children according to socioeconomic status.
    Gosselin V; Généreux M; Gagneur A; Petit G
    Hum Vaccin Immunother; 2016 Oct; 12(10):2572-2579. PubMed ID: 27367155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Equity and impact: Ontario's infant rotavirus immunization program five years following implementation. A population-based cohort study.
    Wilson SE; Rosella LC; Wang J; Renaud A; Le Saux N; Crowcroft NS; Desai S; Harris T; Bolotin S; Gubbay J; Deeks SL
    Vaccine; 2019 Apr; 37(17):2408-2414. PubMed ID: 30765171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hospital-based surveillance of rotavirus gastroenteritis in the era of limited vaccine uptake through the private sector.
    Trimis G; Koutsoumbari I; Kottaridi C; Palaiologou N; Assimakopoulou E; Spathis A; Lebessi E; Konstantopoulos A; Kafetzis D; Karakitsos P; Papaevangelou V
    Vaccine; 2011 Oct; 29(43):7292-5. PubMed ID: 21816195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rotavirus gastroenteritis in Finnish children in 2006-2008, at the introduction of rotavirus vaccination.
    Räsänen S; Lappalainen S; Halkosalo A; Salminen M; Vesikari T
    Scand J Infect Dis; 2011 Jan; 43(1):58-63. PubMed ID: 20807022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of rotavirus vaccine in reducing hospitalization rates in pediatric patients: a single center experience in Italy.
    Dettori S; Cortesia I; Mariani M; Opisso A; Mesini A; Saffioti C; Castagnola E
    Hum Vaccin Immunother; 2021 Dec; 17(12):5646-5649. PubMed ID: 34766869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008-2018).
    Hemming-Harlo M; Gylling A; Herse F; Haavisto I; Nuutinen M; Pasternack M; Kanibir MN; Hartwig S; Carias C
    Vaccine; 2022 Jun; 40(29):3942-3947. PubMed ID: 35641360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination.
    Clarke MF; Davidson GP; Gold MS; Marshall HS
    Vaccine; 2011 Jun; 29(29-30):4663-7. PubMed ID: 21575665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occurrence of severe rotavirus gastroenteritis in children younger than three years of age before and after the introduction of rotavirus vaccine: a prospective observational study in four pediatric clinics in Shibata City, Niigata Prefecture, Japan.
    Oishi T; Matsunaga M; Nakano T; Sudo S; Kuwajima H; Tokuriki S; Study SR
    Hum Vaccin Immunother; 2020 Oct; 16(10):2495-2501. PubMed ID: 32609565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice.
    Bégué RE; Perrin K
    Pediatrics; 2010 Jul; 126(1):e40-5. PubMed ID: 20587671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of effectiveness of universal rotavirus vaccination in Southwestern Vietnam based on a dynamic mathematical model.
    Lee T; Kang JM; Ahn JG; Thuy Truong DT; Nguyen TV; Ho TV; Thanh Ton HT; Le Hoang P; Kim MY; Yeom JS; Lee J
    Sci Rep; 2024 Feb; 14(1):4273. PubMed ID: 38383679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Routine Rotavirus Vaccination in Germany: Evaluation Five Years After Its Introduction.
    Marquis A; Koch J
    Pediatr Infect Dis J; 2020 Jul; 39(7):e109-e116. PubMed ID: 32187139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal trends in hospitalization for rotavirus gastroenteritis: A nationwide study in Italy, 2005-2012.
    Mattei A; Sbarbati M; Fiasca F; Angelone AM; Mazzei MC; di Orio F
    Hum Vaccin Immunother; 2016; 12(2):534-9. PubMed ID: 26337458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 4-year study on clinical characteristics of children hospitalized with rotavirus gastroenteritis.
    Wildi-Runge S; Allemann S; Schaad UB; Heininger U
    Eur J Pediatr; 2009 Nov; 168(11):1343-8. PubMed ID: 19205732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Universal Mass Vaccination Against Rotavirus: Indirect Effects on Rotavirus Infections in Neonates and Unvaccinated Young Infants Not Eligible for Vaccination.
    Prelog M; Gorth P; Zwazl I; Kleines M; Streng A; Zlamy M; Heinz-Erian P; Wiedermann U
    J Infect Dis; 2016 Aug; 214(4):546-55. PubMed ID: 27190178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.